Clinical implications of phosphorylated STAT3 expression in de Novo diffuse large B-cell lymphoma.
Clinical Cancer Research.
Times cited: 21
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program.
Times cited: 18